Pyrazolo[1,5-c]pyrimidines

US7745446B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Thomas Maier · Stockach, DE
• Armin Zuelch · Konstanz, DE
• Thomas Ciossek · Oebisfelde, DE
• Thomas Baer · Edgerton, US
• Thomas Beckers · Konstanz, DE

Key dates

• Filing date: Sep 5, 2005
• Grant date: Jun 29, 2010
• Expiry date: Aug 13, 2027

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of a certain formula Iin which R1, R2, R3 and R4 have the meanings indicated in the description are novel compounds expected to be useful in the therapy of (hyper)proliferative diseases and/or disorders responsive to induction of apoptosis.